Botensilimab (BOT) is a human Fc enhanced multifunctional anti-CTLA-4 antibody designed to boost both innate and adaptive anti-tumor immune responses. Its novel design leverages mechanisms of action ...

LEXINGTON, Mass., June 25, 2026--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that three-year survival data from the Phase 1b C-800-01 study of ...

A patch of dirt at the corner of E. 120th St. and Second Ave. is the launch site for the next phase of the Second Avenue Subway. (Evan Simko-Bednarski / New York Daily News) Gov. Hochul, Sen. Chuck ...

First presentation of BOT+BAL melanoma data in heavily pretreated patients whose disease had resisted prior checkpoint therapy and who had poor-risk disease features In the overall BOT+BAL treated ...

The Devil Wears Prada 2 is bringing together all the brands to celebrate its upcoming release. First, clothing, alcohol, and water, but now Starbucks is getting in on The Devil Wears Prada Universe.

Study highlights novel multi-mechanistic immunotherapy combination in checkpoint-refractory disease Data expected to inform immune modulation, treatment sequencing, and durability of response across ...

The biggest stories of the day delivered to your inbox.

A phase 2 study of Pfizer’s atirmociclib has hit its primary endpoint, providing evidence that the CDK4 inhibitor improves progression-free survival (PFS) in second-line metastatic breast cancer. But ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN) today reported financial results for the fourth quarter and full year ended December 31, 2025, highlighting progress for the botensilimab ...

Town of Lincoln, MA (Owner) invites sealed Bids for Lincoln Road Water Main Replacement – Phase 2 for replacement of approximately 5,450 linear feet of 12-inch water main to replace the existing ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...